$3.67
1.94% day before yesterday
Nasdaq, Dec 24, 09:48 pm CET
ISIN
US34960Q1094
Symbol
FBIO

Fortress Biotech, Inc. Stock price

$3.67
+1.12 43.92% 1M
+1.88 105.03% 6M
+1.65 81.23% YTD
+1.86 102.76% 1Y
-4.56 55.40% 3Y
-47.78 92.87% 5Y
-36.83 90.94% 10Y
-146.33 97.55% 20Y
Nasdaq, Closing price Wed, Dec 24 2025
+0.07 1.94%
ISIN
US34960Q1094
Symbol
FBIO
Industry

Key metrics

Basic
Market capitalization
$113.9m
Enterprise Value
$81.1m
Net debt
positive
Cash
$86.2m
Shares outstanding
31.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.8 | 1.5
EV/Sales
1.3 | 1.1
EV/FCF
negative
P/B
2.0
Financial Health
Equity Ratio
15.8%
Return on Equity
-245.8%
ROCE
-48.9%
ROIC
-90.6%
Debt/Equity
1.0
Financials (TTM | estimate)
Revenue
$62.3m | $74.8m
EBITDA
$-55.7m | $-127.3m
EBIT
$-62.3m | $-101.3m
Net Income
$-5.3m | $-19.9m
Free Cash Flow
$-66.1m
Growth (TTM | estimate)
Revenue
-0.3% | 29.7%
EBITDA
43.7% | -18.1%
EBIT
39.8% | 8.9%
Net Income
90.7% | 64.3%
Free Cash Flow
38.3%
Margin (TTM | estimate)
Gross
71.6%
EBITDA
-89.4% | -170.2%
EBIT
-100.0%
Net
-8.6% | -26.6%
Free Cash Flow
-106.2%
More
EPS
$-0.2
FCF per Share
$-2.1
Short interest
15.0%
Employees
101
Rev per Employee
$570.0k
Show more

Is Fortress Biotech, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Fortress Biotech, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Fortress Biotech, Inc. forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Fortress Biotech, Inc. forecast:

Buy
88%
Hold
13%

Financial data from Fortress Biotech, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
62 62
0% 0%
100%
- Direct Costs 18 18
28% 28%
28%
45 45
18% 18%
72%
- Selling and Administrative Expenses 109 109
35% 35%
174%
- Research and Development Expense 22 22
64% 64%
36%
-56 -56
44% 44%
-89%
- Depreciation and Amortization 6.62 6.62
46% 46%
11%
EBIT (Operating Income) EBIT -62 -62
40% 40%
-100%
Net Profit -5.34 -5.34
91% 91%
-9%

In millions USD.

Don't miss a Thing! We will send you all news about Fortress Biotech, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fortress Biotech, Inc. Stock News

Neutral
GlobeNewsWire
11 days ago
MIAMI, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) and its majority-owned subsidiary, Cyprium Therapeutics, Inc. (“Cyprium”), today announced that the U.S. Food and Drug Administration (“FDA”) has accepted the resubmission of the New Drug Application (“NDA”) for CUTX-101 (copper histidinate), intended to treat Menkes disease in pediatric patients. The re...
Neutral
GlobeNewsWire
16 days ago
Clinical trial achieved all three primary objectives with no significant safety issues being reported Results indicate that Emrosi can be safely used for up to 16 weeks with no detectable impact on skin, GI tract or vaginal microbiota FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United Sta...
Neutral
GlobeNewsWire
about one month ago
Total net revenue increased 20.5% to $17.6 million for third quarter of 2025 compared to the third quarter of 2024 Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress received ~$28 million at closing and is eligible to receive up to an additional $4.8 million under a contingent value right (CVR), plus a 2.5% royalty on future net sales of UNLOXCYT™ (cosibelimab-ipdl) Do...
More Fortress Biotech, Inc. News

Company Profile

Fortress Biotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development. The company was founded on June 28, 2006 and is headquartered in New York, NY.

Head office United States
CEO Lindsay Rosenwald
Employees 101
Founded 2006
Website www.fortressbiotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today